Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Data from a phase 3 study indicated the microbiota-based live biotherapeutic RBL was safe and efficacious for recurrent CDI prevention in immunocompromised patients.

For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities persist.

According to a recent study, glucagon-like peptide-1 receptor agonists are associated with a reduction in alcohol intake.

Children with DKA had an increased likelihood of positive celiac serologies, and those with positive tTG-IgA had higher HbA1c concentrations.

Eating a healthy diet is linked to girls having their first menstrual period at an older age than those who consume a less healthy diet.

Trump signed an executive order instructing the HHS to align Medicare payments for drugs with the lowest prices paid by other nations.

Obesity did not significantly impact colonic endoscopic submucosal dissection results, but overtubes were used more for right-sided lesion dissection.

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

Among Medicare beneficiaries with IBD, Black, Asian, and Hispanic patients have lower health care utilization patterns than White patients.

The Liver Transplant Comorbidity Index, developed from FrAILT study results, identified patients at high risk for mortality at 3 years post-liver transplant.

President Donald Trump has chosen Dr Casey Means, a wellness influencer and health tech entrepreneur, to be his nominee for surgeon general.